US · LIMNW
Liminatus Pharma, Inc. Warrants
- Sector
- Healthcare · Biotechnology
- Headquarters
- La Palma, CA 90623
- Website
- liminatuspharma.com
Price · as of 2026-08-31
$0.06
Market cap 2.59M
Price history
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | — | — |
| P/E | -0.14 | |
| P/B | -0.15 | |
| P/S | — | |
| EV/EBITDA | -0.25 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $0.06 |
About Liminatus Pharma, Inc. Warrants
Back to about heading
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
- CEO
- Chris Kim
- Employees
- 3
- Beta
- 0.76
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| LIMNW | Liminatus Pharma, Inc. Wa… | $0.04 | 2.59M | — | — | -0.14 | -0.15 | — | -0.25 | — |
| ARTL | Artelo Biosciences, Inc. | $1.46 | 3.41M | — | — | -0.69 | -6.97 | — | -0.71 | — |
| BCTXZ | BriaCell Therapeutics Cor… | $0.08 | 150.51K | — | — | — | — | — | — | — |
| BIVI | BioVie Inc. | $1.44 | 10.86M | — | — | -0.15 | 0.14 | — | 0.82 | — |
| ELAB | PMGC Holdings Inc. | $1.92 | 3.72M | — | — | -0.01 | 0.01 | 0.16 | 0.37 | -76.08% |
| GLMD | Galmed Pharmaceuticals Lt… | $0.68 | 3.71M | — | — | -0.26 | 0.17 | — | 1.81 | — |
| MLEC | Moolec Science S.A. | $7.20 | 5.23M | — | — | -0.07 | -0.12 | 0.02 | -3.56 | 5830.74% |
| PTIX | Protagenic Therapeutics, … | $0.52 | 943.12K | — | — | -4.00 | 21.80 | — | -3.70 | — |
| VRAX | Virax Biolabs Group Limit… | $0.21 | 918.76K | — | — | -0.50 | 0.53 | 478.92 | 0.14 | -95.95% |
| XRTX | XORTX Therapeutics Inc. | $2.26 | 629.39K | — | — | -0.14 | 0.18 | — | 0.14 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.06) − 1 = — (IC, example).